TSE:4547Pharmaceuticals
Kissei Pharmaceutical (TSE:4547) One Off Gain Lifts Margin And Tests Bullish Earnings Narrative
Kissei Pharmaceutical (TSE:4547) has just wrapped up FY 2026 with fourth quarter revenue of ¥24.8b and Basic EPS of ¥66.70, rounding out a year in which trailing twelve month revenue reached ¥97.4b and EPS came in at ¥331.53. Over the past few quarters the company has seen revenue move from ¥22.7b and EPS of ¥72.91 in Q4 FY 2025 to ¥24.8b and EPS of ¥66.70 in Q4 FY 2026, while trailing net profit over the last year totaled ¥13.8b as margins edged higher. With a 14.1% net margin and a current...